GoldenGolden
Sema4 (Mount Sinai Genomics, Inc.)

Sema4 (Mount Sinai Genomics, Inc.)

Mount Sinai Genomics is a Connecticut-based medical genetics practice at the Mount Sinai Health System.

Overview

Sema4 is a Stamford, Connecticut-based, interdisciplinary health information company that specializes in screening, diagnosis, counseling, and treatment of patients with or suspected of having genetic disease, birth defects, hereditary cancer susceptibility, or reproductive-related genetic disorders. The company spun out from the Mount Sinai Health System and was known formerly as the Mount Sinai Genetic Testing Lab at the Icahn School of Medicine at Mount Sinai. The company was founded in 2017 by Eric Schadt.

Timeline

June 17, 2021
Sema4 announces the appointment of Andrew Kasarskis, PhD, to the newly established role of Chief Data Officer (CDO).
February 10, 2021
Sema4 announces its plan to combine with CM Life Sciences to accelerate growth.
July 29, 2020
Sema4 raises a $121,000,000 series C round from BlackRock, Blackstone Group, Connecticut Innovations, Decheng Capital, Deerfield, Moore Strategic Ventures, Oak HC/FT and Section 32.
July 29, 2020
Sema4 raises a $121,000,000 series C round from BlackRock, Blackstone Group, Connecticut Innovations, Decheng Capital, Deerfield, Moore Strategic Ventures, Oak HC/FT and Section 32.
August 30, 2019
Sema4 raises a $120,000,000 series B round from Blackstone Group, Connecticut Innovations, Decheng Capital, Oak HC/FT and Section 32.
June 1, 2017
Mount Sinai Health System introduces a spinout company, Sema4.

The Mount Sinai Health System spun out several genetic testing and data sciences components from its Department of Genetics and Genomic Sciences and the Icahn Institute for Genomics and Multiscale Biology into a for-profit company, Sema4.

Funding rounds

People

Name
Role
LinkedIn

Alan Copperman

Employee

Andrew Adams

Board Advisor

Andrew ElBardissi

Board Member

Bobbie Lyons

Employee

Bridget Winders

Employee

Dan Clark

Employee

David Bellaire

Employee

David Windreich

Board Member

David Zirl

Employee

Dennis Charney

Board Member

Eric Schadt

Founder, CEO, & Board Member

Glenn Farrell

CMO & EVP

Isaac Ro

CFO

James Coffin

President & COO

Joshua Ruch

Board Member

Jun Zhu

Employee

Kareem Saad

Employee

Ke Hao

Employee

Kenneth Davis

Board Member

Krish Ghosh

Employee

Lauren Peters

Employee

Li Li

Employee

Lisa Edelmann

CDO

Matt Phillips

Employee

Michelle Zimmerman

Employee

Page 1 of 2

Further reading

Title
Author
Link
Type
Date

A functional genomics predictive network model identifies regulators of inflammatory bowel disease

Lauren A Peters, Jacqueline Perrigoue, Arthur Mortha, Alina Iuga, Won-min Song, Eric M Neiman, Sean R Llewellyn, Antonio Di Narzo, Brian A Kidd, Shannon E Telesco, Yongzhong Zhao, Aleksandar Stojmirovic, Jocelyn Sendecki, Khader Shameer, Riccardo Miotto, Bojan Losic, Hardik Shah, Eunjee Lee, Minghui Wang, Jeremiah J Faith, Andrew Kasarskis, Carrie Brodmerkel, Mark Curran, Anuk Das, Joshua R Friedman, Yoshinori Fukui, Mary Beth Humphrey, Brian M Iritani, Nicholas Sibinga, Teresa K Tarrant, Carmen Argmann, Ke Hao, Panos Roussos, Jun Zhu, Bin Zhang, Radu Dobrin, Lloyd F Mayer, and Eric E Schadt

Web

2015

Assembly and diploid architecture of an individual human genome via single-molecule technologies

Matthew Pendleton, Robert Sebra, Andy Wing Chun Pang, Ajay Ummat, Oscar Franzen, Tobias Rausch, Adrian M Stütz, William Stedman, Thomas Anantharaman, Alex Hastie, Heng Dai, Markus Hsi-Yang Fritz, Han Cao, Ariella Cohain, Gintaras Deikus, Russell E Durrett, Scott C Blanchard, Roger Altman, Chen-Shan Chin, Yan Guo, Ellen E Paxinos, Jan O Korbel, Robert B Darnell, W Richard McCombie, Pui-Yan Kwok, Christopher E Mason, Eric E Schadt, and Ali Bashir

Web

2014

From smartphone to EHR: a case report on integrating patient-generated health data

Nicholas Genes, Samantha Violante, Christine Cetrangol, Linda Rogers, Eric E. Schadt, and Yu-Feng Yvonne Chan

Web

2014

Gaining comprehensive biological insight into the transcriptome by performing a broad-spectrum RNA-seq analysis

Sayed Mohammad Ebrahim Sahraeian, Marghoob Mohiyuddin, Robert Sebra, Hagen Tilgner, Pegah T. Afshar, Kin Fai Au, Narges Bani Asadi, Mark B. Gerstein, Wing Hung Wong, Michael P. Snyder, Eric Schadt, and Hugo Y. K. Lam

Web

2013

Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment

Ayers, Kristin L, Glicksberg, Benjamin S, Garfield, Alastair S, Longerich, Simonne, White, Joseph A, Yang, Pengwei, Du, Lei, Chittenden, Thomas W, Gulcher, Jeffery R, Roy, Sophie, Fiedorek, Fred, Gottesdiener, Keith, Cohen, Sarah, North, Kari E, Schadt, Eric E, Li, Shuyu D, Chen, Rong, Van der Ploeg, Lex H T

Web

May 2, 2018

Metagenomic binning and association of plasmids with bacterial host genomes using DNA methylation

John Beaulaurier, Shijia Zhu, Gintaras Deikus, Ilaria Mogno, Xue-Song Zhang, Austin Davis-Richardson, Ronald Canepa, Eric W Triplett, Jeremiah J Faith, Robert Sebra, Eric E Schadt, and Gang Fang

Web

2012

Oxidized phospholipids regulate amino acid metabolism through MTHFD2 to facilitate nucleotide release in endothelial cells

Juliane Hitzel, Eunjee Lee, Yi Zhang, Sofia Iris Bibli, Xiaogang Li, Sven Zukunft, Beatrice Pflüger, Jiong Hu, Christoph Schürmann, Andrea Estefania Vasconez, James A. Oo, Adelheid Kratzer, Sandeep Kumar, Flávia Rezende, Ivana Josipovic, Dominique Thomas, Hector Giral, Yannick Schreiber, Gerd Geisslinger, Christian Fork, Xia Yang, Fragiska Sigala, Casey E. Romanoski, Jens Kroll, Hanjoong Jo, Ulf Landmesser, Aldons J. Lusis, Dmitry Namgaladze, Ingrid Fleming, Matthias S. Leisegang, Jun Zhu, and Ralf P. Brandes

Web

2016

Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes

Matthew D. Galsky, Huan Wang, Noah M. Hahn, Przemyslaw Twardowski, Sumanta K. Pal, Costantine Albany, Mark T. Fleming, Alexander Starodub, Ralph J. Hauke, Menggang Yu, Qianqian Zhao, Guru Sonpavde, Michael J. Donovan, Vaibhav G. Patel, John P. Sfakianos, Josep Domingo-Domenech, William K. Oh, Nicholas Akers, Bojan Losic, Sacha Gnjatic, Eric E. Schadt, Rong Chen, Seunghee Kim-Schulze, Nina Bhardwaj, and Andrew V. Uzilov

Web

Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth

Web

February 10, 2021

The asthma mobile health study, smartphone data collected using ResearchKit

Yu-Feng Yvonne Chan, Brian M. Bot, Micol Zweig, Nicole Tignor, Weiping Ma, Christine Suver, Rafhael Cedeno, Erick R. Scott, Steven Gregory Hershman, Eric E. Schadt, and Pei Wang

Web

2017

Documentaries, videos and podcasts

Title
Date
Link

Sema4 - Corporate Video

October 23, 2019

Sema4 Webcast - CATCHING CANCER EARLY

October 20, 2020

Sema4 Webcast - Impact of COVID-19 on Gamete Donor Collection

May 27, 2020

Sema4 Webcast - Navigating a Safe Return to Reproductive Care: Reopening IVF Centers During COVID-19

May 6, 2020

Sema4 Webcast - The Seismic Shift: COVID-19, Testing and The Digital Health Revolution

April 20, 2020

Sema4 Webcast - The Virtual Patient Experience: Embracing an on-demand style of digital care

May 26, 2020

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Andrea Park
June 17, 2021
FierceBiotech
With a handful of new genomics and data analytics partnerships under its belt and plans to go public through a SPAC deal this summer, Sema4 is now on a mad dash to fill out its C-suite.
BioSpace
June 17, 2021
BioSpace
Sema4 today announced the appointment of Andrew Kasarskis , PhD, to the newly established role of Chief Data Officer (CDO).
Monteverde & Associates PC
February 13, 2021
www.prnewswire.com:443
/PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS...
WeissLaw LLP
February 11, 2021
www.prnewswire.com:443
/PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CM Life Sciences,...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.